On October 25, 2021, Kanghua Bio (300841.SZ) released the third quarter report of 2021, achieving operating income of 228 million yuan, down 38.33% year-on-year; net profit attributable to shareholders of listed companies of 331 million yuan, an increase of 105.74% year-on-year; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 99.9315 million yuan, down 37.74% year-on-year; basic earnings per share of 3.6799 yuan.
This article originated from Grand Gateway
![#央媒批 "The operating room is full of money" # ["The operating room is full of money", some hospitals "only do not say", Kanghua Hospital "do what you say"] "The operating room is full of money", this banner[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)